Ascending Single Dose Study of Rhu-pGelsolin in Patients With Decreased Gelsolin Levels
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard C Straube, MD
Critical Biologics Corporation
Study Chair - Selene Tam, PhD
University of Hong Kong; Clinical Trials Centre
Study Director - Wai M Chan, MBBS
Queen Mary Hospital, Hong Kong
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Queen Mary Hospital; University of Hong Kong
Hong Kong, SAR, Hong Kong
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2008
- Primary completion
- 31 Mar 2010
- Completion
- 31 May 2010
- Last update posted
- 29 Sept 2010
- Registered enrollment
- 40
- Registry id
- NCT00671307
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.